Sun Pharma Announces US FDA Approval for Generic Mesalamine Extended Release Capsules.
Press Release May 12 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Press Release Mar 30 2022
- Press Release Mar 25 2022
- Press Release Jan 31 2022
- Sun Pharma launches PrCEQUA, the first dry eye treatment with nanomicellar technology, in Canada
- Press Release Jan 27 2022
Later from Sun Pharmaceutical Industries
- Press Release May 16 2022
- Press Release May 18 2022
- Press Release May 27 2022
- Press Release May 30 2022
- Press Release Jul 26 2022
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries